These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 7445781)

  • 1. [Quantitative DNCB reaction in patients with hypernephroma].
    Kreutz G; Bandhauer K
    Z Urol Nephrol; 1980 Feb; 73(2):73-8. PubMed ID: 7445781
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNCB and PPD skin tests and prognosis in 152 patients with breast cancer. A prospective 2-year follow-up.
    Munzarová M; Kovarík J; Hlávková J; Popelínský L; Lauerová L
    Neoplasma; 1985; 32(1):45-50. PubMed ID: 3982560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [DNCB-skin specimens for immunodiagnosis].
    Sinn W
    Z Gesamte Inn Med; 1981 Sep; 36(17):602-7. PubMed ID: 7345806
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The DNCB skin test and its comparison with the radioimmunological determination of CEA in some types of neoplasms].
    Bianucci P; Pastorino G; De Rossi O
    Minerva Med; 1979 May; 70(25):1795-801. PubMed ID: 572515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the dinitrochlorobenzene (DNCB) sensitization test.
    Niwa Y; Niwa H; Kohmura J; Ou DW; Yokoyama MM
    Ann Allergy; 1982 Feb; 48(2):108-12. PubMed ID: 7199878
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic implications of cellular immune defects in operable cancer patients revealed by dinitrochlorobenzene skin contact sensitivity.
    Ketcham AS; Chretien PB
    Panminerva Med; 1975; 17(5-6):174-8. PubMed ID: 1057759
    [No Abstract]   [Full Text] [Related]  

  • 7. [The possible evaluation of immunity with the DNCB skin test in relation to blast transformation of lymphocytes].
    Bianucci P; Pastorino G; Brondi P
    Minerva Med; 1982 Oct; 73(41):2891-5. PubMed ID: 7133502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Skin sensitization to 2, 4 dinitrochlorobenzene (DNCB) in the first months of life.
    Cassimos C; Kanakoudi-Tsakalidis F; Spyroglou K; Ladianos M; Tzaphi R
    J Clin Lab Immunol; 1980 Mar; 3(2):111-3. PubMed ID: 7205930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The prognostic significance of the immune status (DNCB-test) in patients with carcinoma of the bladder, checked by observation of the course of disease (author's transl)].
    Flamm J; Burkert S
    Wien Med Wochenschr; 1981; 131(13-14):339-43. PubMed ID: 7281701
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of skin testing with dinitrochlorobenzene in patients with head and neck cancer.
    Osoba D; Kersey PA; Clark RM; Rosen IB
    Can J Surg; 1980 Jan; 23(1):43-4. PubMed ID: 7363157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study of the DNCB skin test in patients with solid neoplasms].
    Mor C; Marcovina S; Moro E; Radice F; Russo R; Trinca E
    Arch Sci Med (Torino); 1978; 135(3):377-82. PubMed ID: 708088
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Examination of immunologic reaction of the cellular type using the DNCB test in patients with bone tumors (author's transl)].
    Lipenský R; Urban K
    Acta Chir Orthop Traumatol Cech; 1979 Dec; 46(6):485-90. PubMed ID: 532518
    [No Abstract]   [Full Text] [Related]  

  • 13. [Experiences with DNCB sensitization in normal human individuals of various age groups (author's transl)].
    Bürkle PA; Tönnesmann E; Ahnefeld S; Nobbe F; Federlin K
    Z Immunitatsforsch Exp Klin Immunol; 1976 Apr; 151(2):153-65. PubMed ID: 134535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Cross allergies following sensitization with dinitrochlorbenzol (DNCB)].
    Djawari D; Körner E; Haneke E
    Hautarzt; 1980 Apr; 31(4):198-202. PubMed ID: 7399912
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [A correlation between the histological parameters such as stromal reaction and cell-mediated immune-structure of the regional lymph nodes, and the delayed cutaneous hypersensitive reaction toward DNCB in cervical cancer (author's transl)].
    Obata N; Kodama S; Hando T; Hirogami T; Takeuchi S
    Nihon Sanka Fujinka Gakkai Zasshi; 1980 May; 32(5):550-8. PubMed ID: 7240843
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Precipitation of type-I (upgrading) reaction in leprosy by skin testing with antigen and irritants.
    Malhotra B; Das KD; Tutakne MA; Aggarwal SK
    Lepr India; 1983 Apr; 55(2):305-9. PubMed ID: 6632784
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tests of cell mediated immunity in patients with early breast cancer. I. Response to DNCB at time of mastectomy.
    Davies CJ; Meredith ID; Robins RA; Blamey RW; Baldwin RW
    Clin Oncol; 1978 Sep; 4(3):227-34. PubMed ID: 750125
    [No Abstract]   [Full Text] [Related]  

  • 18. Sequential evaluation of DNCB reactivity in patients with primary lung cancer. Correlation with prognosis.
    Inoue H; Ishihara T; Kobayashi K; Fukai S
    J Thorac Cardiovasc Surg; 1978 Oct; 76(4):479-82. PubMed ID: 703354
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantitative DNCB epicutaneous sensitization in leprosy patients and controls.
    Sivamani S; Garg BR; Lal S
    Lepr India; 1981 Jan; 53(1):45-51. PubMed ID: 7218763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular evaluation of hypersensitivity to 2,4-dinitrochlorobenzene.
    Jansa P
    Neoplasma; 1977; 24(5):529-32. PubMed ID: 927609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.